<DOC>
	<DOCNO>NCT03012165</DOCNO>
	<brief_summary>A Multi-Center , Double-Masked , Randomized , Vehicle-Controlled , Phase 2b Evaluation Onset Duration ADX-102 Ophthalmic Drops ( 0.5 % 0.1 % ) Compared Vehicle ADX-102 Ophthalmic Drops Conjunctival Allergen Challenge ( Ora-CACÂ® ) Model Acute Allergic Conjunctivitis .</brief_summary>
	<brief_title>A Study ADX-102 Subjects With Allergic Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>least 18 year age either gender race positive history ocular allergy positive skin test reaction seasonal ( grass , ragweed , and/or tree ) perennial allergen ( cat dander , dog dander , dust mite , cockroach ) confirm allergic skin test within past 24 month calculate visual acuity 0.7 logMAR good eye measure use ETDRS chart know contraindication sensitivity use investigational product component ocular condition , opinion investigator , could affect subject 's safety trial parameter ( include limit narrow angle glaucoma , clinically significant blepharitis , follicular conjunctivitis , iritis , pterygium diagnosis dry eye ) ocular surgical intervention within three ( 3 ) month prior Visit 1 study and/or history refractive surgery within past six ( 6 ) month know history retinal detachment , diabetic retinopathy , active retinal disease presence active ocular infection ( bacterial , viral fungal ) positive history ocular herpetic infection visit female currently pregnant , planning pregnancy , lactating , use medically acceptable form birth control throughout study duration 14 day prior installation investigational product , positive urine pregnancy test Visit 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>ADX-102</keyword>
	<keyword>Allergic Conjunctivitis</keyword>
</DOC>